{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-23-005127","form_type":"8-K","ticker":"DDD","cik":"0000910638","company_name":"3D SYSTEMS CORP","filed_at":"2023-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.992095+00:00","generated_at":"2026-06-12T00:03:55.150969+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"3D Systems Q2 revenue $128.2M (-8.5% YoY), net loss $28.9M; cuts FY2023 guidance to $525-545M","bullets":["Q2 revenue $128.2M (down 8.5% YoY); net loss $28.9M ($0.22 GAAP EPS loss); non-GAAP EPS loss $0.07.","Dental orthodontics revenue declined ~$50M over 4 quarters; full-year dental expected down ~35%.","FY2023 revenue guidance cut to $525-545M (from $545-575M); positive Adj. EBITDA now expected in Q4 2023.","CEO frustrated by lack of engagement from Stratasys on proposed merger; deal signed in escrow on July 13.","Healthcare Solutions revenue down 15.2% YoY; Industrial down 1.4%; non-dental organic growth ~2% YTD."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-23-005127","json":"https://secwatch.observer/filing/0001171843-23-005127.json","markdown":"https://secwatch.observer/filing/0001171843-23-005127.md","text":"https://secwatch.observer/filing/0001171843-23-005127.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/910638/000117184323005127/0001171843-23-005127-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/910638/000117184323005127/f8k_080923.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T00:03:55.150969+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"975615601eff6efd6d50d3bdd8eb02fa4ab018eb","claim":"3D SYSTEMS CORP reported second quarter ended June 30, 2023 results: revenue $128,194, net income $28,895, EPS $0.22. Guidance lowered.","evidence_excerpt":"Financial Results and Recent Business Highlights (All numbers are unaudited and are presented in thousands, except per share amounts or as otherwise noted) Q2 2023 revenue of $128,194 and year-to-date revenue of $249,430 decreased from the prior year by 8.5% and 8.6% respectively, predominantly driven by expected weakness in the dental orthodontics markets","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/910638/000117184323005127/0001171843-23-005127-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended June 30, 2023"},{"label":"Revenue","value":"$128,194"},{"label":"Net income","value":"$28,895"},{"label":"EPS","value":"$0.22"},{"label":"Guidance","value":"lowered"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}